Jobs / United States / Gilead Sciences INC
Senior Scientist, Molecular Biology
Gilead Sciences INC · 🇺🇸 United States - California - Foster City
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Gilead Sciences INC paid sponsored hires in similar roles11 certified filings for “Principal Scientist, Bioinformatics” (Molecular and Cellular Biologists) in CA: $125k–$184k, median $168k. Most were filed at wage level IV (55%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Gilead Sciences INC
The US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Gilead Sciences INC →
About the role
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together. Job Description At Gilead our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV treatment and prevention as well as advancements in therapies for viral and inflammatory diseases and certain cancers. We set and achieve bold ambitions in our fight against the world’s most devastating diseases, united in our commitment to confronting the largest public health challenges of our day and improving the lives of patients for generations to come. The Protein Therapeutics department is seeking a highly motivated laboratory-based scientist to lead the Molecular Biology function within the Mammalian Expression team. In this capacity, the successful candidate will provide scientific direction for the design, development, and execution of high-throughput expression construct and cassette generation workflows that support Gilead’s therapeutic programs in areas such as Virology, Inflammation, and Oncology. This individual will spearhead initiatives to advance integrated synthetic biology workflows, facilitating efficient transitions from sequence design in silico to high-quality, expression-ready constructs for recombinant protein expression at all scales. The ideal candidate will possess extensive molecular biology expertise, collaborative leadership skills, and a proven track record in developing and optimizing robust, data-driven platforms that accelerate gene-to-protein delivery across diverse projects. Key Responsibilities: • Provide scientific and operational guidance for the molecular cloning function, overseeing the design and delivery of complex plasmid and expression constructs utilizing various assembly technologies including Gibson, Golden Gate, and In-Fusion cloning, with workflows tailored for scalable automation. • Lead the development and enhancement of high-throughput construct generation platforms by integrating robotic systems and innovative technologies to expand capacity and reduce cycle time in gene-to-protein workflows. • Direct the implementation and ongoing refinement of automated sequence verification workflow, including management of external CRO activities to ensure high-quality data generation and capture. Oversee rigorous sample quality control to maintain high standards of data accuracy and compliance. • Collaborate strategically with Research Informatics and cross-functional teams to establish standardized, compliant workflows for nucleic acid data registration, streamline operations, and strengthen digital connectivity throughout the workflow. • Supervise and drive continuous improvement of the Protein Therapeutic